[1] Ferlay J, SteliarovaFoucher E, LortetTieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012[J]. Eur J Cancer, 2013, 49(6): 13741403. DOI: 10.1016/j.ejca.2012.12.027.
[2] Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2): 6990. DOI: 10.3322/caac.20107.
[3] Chen B, Cao L, Zhou Y, et al. Glutathione Stransferase T1 (GSTT1) gene polymorphism and gastric cancer susceptibility: a metaanalysis of epidemiologic studies[J]. Dig Dis Sci, 2010, 55(7): 18311838. DOI: 10.1007/s1062000910004.
[4] Zhan P, Wang J, Zhang Y, et al. CYP2E1 RsaⅠ/PstⅠ polymorphism is associated with lung cancer risk among Asians[J]. Lung Cancer, 2010, 69(1): 1925. DOI: 10.1016/j.lungcan.2009.09.001.
[5] Balaji L, Singh KB, Bhaskar L. Genetic polymorphisms of the CYP2E1 gene do not contribute to oral cancer susceptibility in South Indians[J]. Asian Pac J Cancer Prev, 2011, 12(6): 15231527.
[6] Deng XD, Gao Q, Zhang B, et al. Functional RsaⅠ/PstⅠ polymorphism in cytochrome P450 2E1 contributes to bladder cancer susceptibility: evidence from a metaanalysis[J]. Asian Pac J Cancer Prev, 2014, 15(12): 49774982.
[7] Leng WD, Zeng XT, Chen YJ, et al. Cytochrome P450 2E1 RsaⅠ/PstⅠ polymorphism and risk of esophageal cancer: A metaanalysis of 17 casecontrol studies[J]. Exp Ther Med, 2012, 4(5): 938948. DOI: 10.3892/etm.2012.687.
[8] Tian Z, Li YL, Zhao L, et al. CYP2E1 RsaⅠ/PstⅠ polymorphism and liver cancer risk among East Asians: a HuGE review and metaanalysis[J]. Asian Pac J Cancer Prev, 2012, 13(10): 49154921.
[9] Feng J, Pan X, Yu J, et al. Functional PstⅠ/RsaⅠ polymorphism in CYP2E1 is associated with the development, progression and poor outcome of gastric cancer[J]. PLoS One, 2012, 7(9): e44478. DOI: 10.1371/journal.pone.0044478.
[10] Malakar M, Devi KR, Phukan RK, et al. CYP2E1 genetic polymorphism with dietary, tobacco, alcohol habits, H. pylori infection status and susceptibility to stomach cancer in Mizoram, India[J]. Asian Pac J Cancer Prev, 2014, 15(20): 88158822.
[11] Zhuo W, Zhang L, Wang Y, et al. CYP2E1 RsaⅠ/PstⅠ polymorphism and gastric cancer susceptibility: metaanalyses based on 24 casecontrol studies[J]. PLoS One, 2012, 7(11): e48265. DOI: 10.1371/journal.pone.0048265. |